F.D.A. Panel Explores Challenges of Revamping Coronavirus Vaccines. Clinical Trials, Coronavirus (2019-nCoV), Vaccination and Immunization, United States Politics and Government, Centers for Disease Control and Prevention, Food and Drug Administration, Health and Human Services Department, Moderna Inc, Pfizer Inc